111 related articles for article (PubMed ID: 32617018)
1. Erratum: Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():4957. PubMed ID: 32617018
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer.
Tseng WT; Lee Y; Hung CF; Lin PY; Chien CY; Chuang HC; Fang FM; Li SH; Huang TL; Chong MY; Wang LJ
Cancer Manag Res; 2019; 11():10297-10305. PubMed ID: 31849519
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancers.
Pirola WE; Paiva BSR; de Oliveira CZ; Lucchetti G; Lucchetti ALG; Kissane D; Paiva CE
Palliat Support Care; 2020 Apr; 18(2):186-192. PubMed ID: 31317847
[TBL] [Abstract][Full Text] [Related]
4. A commentary on: Pirola et al. (2019) "Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancers".
Miguel S; Caldeira S
Palliat Support Care; 2020 Apr; 18(2):250-251. PubMed ID: 31554522
[No Abstract] [Full Text] [Related]
5. Assessment of Shame and Stigma in Head and Neck Cancer: A Meta-Analysis.
Goyal AK; Bakshi J; Panda NK; Kapoor R; Vir D; Kumar K; Aneja P
J Maxillofac Oral Surg; 2024 Feb; 23(1):16-22. PubMed ID: 38312965
[TBL] [Abstract][Full Text] [Related]
6. Preliminary evaluation of the reliability and validity of the Shame and Stigma Scale in head and neck cancer.
Kissane DW; Patel SG; Baser RE; Bell R; Farberov M; Ostroff JS; Li Y; Singh B; Kraus DH; Shah JP
Head Neck; 2013 Feb; 35(2):172-83. PubMed ID: 22368160
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China [Corrigendum].
Cancer Manag Res; 2020; 12():8409. PubMed ID: 32982434
[TBL] [Abstract][Full Text] [Related]
8. Erratum: The Development of a Nomogram to Predict Post-Radiation Necrosis in Nasopharyngeal Carcinoma Patients: A Large-Scale Cohort Study [Corrigendum].
Cancer Manag Res; 2020; 12():1371. PubMed ID: 32161491
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum].
Cancer Manag Res; 2022; 14():409-410. PubMed ID: 35140518
[TBL] [Abstract][Full Text] [Related]
10. Erratum: The Blood Biomarkers of Thyroid Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():49-50. PubMed ID: 35023970
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Intraoperative Prediction of Non-Sentinel Lymph Node Metastasis Based on the Molecular Assay in Breast Cancer Patients [Corrigendum].
Cancer Manag Res; 2020; 12():1875. PubMed ID: 32214845
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():4967. PubMed ID: 34188549
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Corrigendum].
Cancer Manag Res; 2023; 15():1319-1320. PubMed ID: 38027236
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women [Corrigendum].
Cancer Manag Res; 2021; 13():3079. PubMed ID: 33854377
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum].
Cancer Manag Res; 2020; 12():3331-3332. PubMed ID: 32494196
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum].
Cancer Manag Res; 2021; 13():8525-8526. PubMed ID: 34849021
[TBL] [Abstract][Full Text] [Related]
17. Erratum: SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():1845-1846. PubMed ID: 35673557
[TBL] [Abstract][Full Text] [Related]
18. Erratum: NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum].
Cancer Manag Res; 2019; 11():10041. PubMed ID: 31819636
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis [Corrigendum].
Cancer Manag Res; 2020; 12():6863. PubMed ID: 32848459
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():6363-6364. PubMed ID: 34408495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
